This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Revenue and profit jump sharply in September 2026 quarter
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 13.0 pts more than Nifty Microcap 250 and 12.5 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
For the quarter ended September 2026, Resonance Specialties reported unaudited revenue of Rs 3,428.76 lakh versus Rs 1,355.27 lakh a year earlier, and net profit of Rs 846.71 lakh. For the half year, revenue was Rs 6,687.17 lakh versus Rs 4,280.77 lakh, while profit rose to Rs 1,421.13 lakh from Rs 328.74 lakh. Earnings per share were Rs 12.31. The auditor's review found no material issue.
Strong profit growth and no bank borrowings are positive for the stock, though low cash and high inventory are risks to monitor.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹34.29 Cr | ₹21.53 Cr | +59.2% |
| Operating profit | ₹10.54 Cr | ₹1.97 Cr | +434.8% |
| Profit after tax | ₹8.47 Cr | ₹1.66 Cr | +411.0% |
| EBITDA margin | 31.8% | 11.0% | +20.8 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.